(Press-News.org) Hydrogen is often touted as the fuel of the future. But because this gas is highly explosive, it must be stored and transported under pressure in specialized and expensive containers. Hydrogen therefore has issues in terms of safety, logistics, and profitability that could significantly limit its wider use. However, a solution might lie in research by EPFL scientists, who have developed a simple system based on two chemical reactions. The first reaction transforms hydrogen into formic acid, a liquid that is easy to store and less flammable than gasoline, while the second reaction does the reverse and restores the hydrogen. Another possible application of their technology would be to use atmospheric CO2 to synthesize a number of useful chemical products.
Gabor Laurenczy's team has already developed a process for transforming formic acid into hydrogen gas. The method was the subject of several articles, one of which appeared in Science, and it is currently under industrial development. But a complete and coherent system would also require the inverse process: transforming hydrogen into formic acid. This has now been achieved, completing the cycle, thanks to the financial support of EOS Holding. The scientists in Laurenczy's team have described the process in a Nature Communications article.
The researchers synthesized formic acid in a single step, starting with hydrogen and atmospheric CO2. Conventional methods to accomplish this involve several steps, which are complicated to carry out and generate undesirable chemical byproducts.
The two chemical reactions – hydrogen to formic acid and back to hydrogen - are catalytic: the advantage is that nothing is lost in the transformation, and the process can thus be used in constructing sustainable devices.
With their two catalytic reactions, the researchers now possess all the technology they need to build a complete, integrated device. Laurenczy envisions small energy storage units in which the current from photovoltaic cells produces hydrogen by electrolysis, which is then transformed and stored as formic acid, and finally transformed back into hydrogen to produce electricity at night-time. "Our procedure is simple enough that it can be implemented at the domestic level," he says.
Another possible application of this technology would be to use atmospheric CO2, a greenhouse gas, as a building-block for chemical synthesis. Formic acid is the basis of numerous organic syntheses, e.g. in the textile industry. As Laurenczy explains: "We are killing two birds with one stone: we could sequester part of the 35 gigatons of CO2 that are emitted into the atmosphere every year, and also use it to synthesize materials."
INFORMATION: END
Transforming hydrogen into liquid fuel using atmospheric CO2
EPFL scientists have completed their solution for transforming hydrogen gas into a less flammable liquid fuel that can be safely stored and transported
2014-06-02
ELSE PRESS RELEASES FROM THIS DATE:
Small businesses less likely to offer health promotion programs
2014-06-02
Employees at small businesses are less likely to have access to worksite wellness programs, according to a research review in the May Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM).
But smaller companies that can overcome the barriers and implement wellness programs can realize achieve meaningful improvements in employee health, report Kira McCoy, BA, of Hampshire College, Amherst, Mass., and colleagues. They write, "Preventative health initiatives and disease management ...
CPAP rapidly improves blood pressure and arterial tone in adults with sleep apnea
2014-06-02
DARIEN, IL – A new study suggests that continuous positive airway pressure (CPAP) therapy rapidly improves blood pressure and arterial tone in adults with obstructive sleep apnea (OSA).
Results show that there was a significant reduction in systolic and diastolic blood pressures among sleep apnea patients who were compliant with CPAP therapy for three months. Successful treatment of sleep apnea also was associated with decreased vascular tone and arterial stiffness. Following one week of treatment withdrawal, these improvements disappeared and reverted to baseline values.
"We ...
Studies reveal new strategies to improve quality of life
2014-06-02
CHICAGO – Key studies released today at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) identify new strategies for easing the short- and long-term effects of cancer therapy and improving the quality of life of patients with cancer, as well as their caregivers.
"We've made incredible strides in cancer treatment, and more cancer survivors are alive today than ever before. But oncology isn't just about helping people live longer – we need to ensure that patients have the best quality of life possible at every stage of their cancer journey, from ...
Studies reveal potential new targeted therapies for common, hard-to-treat cancers
2014-06-02
CHICAGO – Positive results from four clinical trials of investigational targeted drugs for advanced ovarian, lung, and thyroid cancers, and chronic lymphocytic leukemia were highlighted today at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO). Findings from the mid- and late-stage trials suggest new ways to slow disease progression and improve survival for patients who experience relapses or resistance to available treatments.
"Cancer relapses and treatment resistance have always been among the most daunting challenges in cancer care," said ...
Clinical trial shows drug combination may be highly effective in recurrent ovarian cancer
2014-06-02
VIDEO:
Dr. Joyce Liu talks about her ovarian cancer research at ASCO 2014.
Click here for more information.
CHICAGO –– Significant improvement with the use of a combination drug therapy for recurrent ovarian cancer was reported at the annual meeting of the American Society of Clinical Oncology (ASCO) meeting in Chicago today. This is the first ovarian cancer study to use a combination of drugs that could be taken orally. The drugs were tested in a phase I combination study followed ...
Drug combination extends survival by more than a year in metastatic prostate cancer
2014-06-02
VIDEO:
Dr. Christopher Sweeney talks about his new study showing a drug combination extends survival by more than a year in metastatic prostate cancer.
Click here for more information.
CHICAGO – Men with newly diagnosed metastatic, hormone-sensitive prostate cancer lived more than a year longer when they received a chemotherapy drug as initial treatment instead of waiting to for the disease to become resistant to hormone-blockers, report scientists from Dana-Farber Cancer Institute ...
Prostate cancer drug delivers benefits before chemotherapy
2014-06-02
PORTLAND, Ore. – A drug used to treat men with late-stage prostate cancer proved effective in stemming progression of the disease in research participants who had not yet received chemotherapy and extended their survival, according to results from a multi-national Phase III clinical trial led by the Knight Cancer Institute at Oregon Health & Science University (OHSU).
A comprehensive analysis of the study's results ― published in June 1 online edition of the New England Journal of Medicine and to be presented at the American Society of Clinical Oncology (ASCO) annual ...
Researchers to provide update on Phase II trial of vaccine for malignant brain tumors
2014-06-02
LOS ANGELES (STRICTLY EMBARGOED UNTIL 7:30 A.M. EDT on JUNE 1, 2014 - ASCO Abstract No. 2005) – A multicenter team of investigators, led by researchers from the Cedars-Sinai Department of Neurosurgery, the Cedars-Sinai Maxine Dunitz Neurosurgical Institute and Dana-Farber Cancer Institute in Boston, have found in a Phase II clinical trial that an immune system-boosting therapy slowed the recurrence of glioblastoma multiforme, or GBM, the most common and deadly malignant brain tumor.
They will present their findings in an oral presentation June 1 at the annual meeting ...
Major advances in breast, prostate, colorectal cancer featured at ASCO Annual Meeting
2014-06-02
CHICAGO – Findings from four phase III clinical trials in breast, prostate, and colorectal cancers were released today at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO). The studies were presented in ASCO's Plenary session, which features the meeting's most important clinical cancer research with the greatest potential to impact patient care.
These pivotal studies reveal new ways to optimize commonly used chemotherapy, hormone therapies, and newer targeted drugs, and answer critical questions about the comparative effectiveness of two common ...
World's best thermometer made from light
2014-06-02
University of Adelaide physics researchers have produced the world's most sensitive thermometer – three times more precise than the best thermometers in existence.
Published in the journal Physical Review Letters, the researchers from the University's Institute for Photonics and Advanced Sensing (IPAS) report they have been able to measure temperature with a precision of 30 billionths of a degree.
"We believe this is the best measurement ever made of temperature − at room temperature," says project leader Professor Andre Luiten, Chair of Experimental Physics in ...
LAST 30 PRESS RELEASES:
Novel treatment combination improves progression-free survival in metastatic, estrogen-receptor-positive HER-2-negative breast cancer
ESMO 2025: Trial results show belzutifan shrinks rare neuroendocrine tumors and improves symptoms in patients
ESMO 2025: Dual targeted therapy shows promise in previously treated advanced kidney cancer patients
New generation of Antibody-Drug Conjugates (ADCs) shows unprecedented promise in early-stage disease
Sylvester Cancer Tip Sheet for October 2025
Three science and technology leaders elected to Hertz Foundation Board of Directors
Jump Trading CSO Kevin Bowers elected to Hertz Foundation Board of Directors
Former Inscripta CEO Sri Kosaraju elected to Hertz Foundation Board of Directors
Citadel’s Jordan Chetty elected to Hertz Foundation Board of Directors
McGill research flags Montreal snow dump, inactive landfills as major methane polluters
A lightweight and rapid bidirectional search algorithm
Eighty-five years of big tree history available in one place for the first time
MIT invents human brain model with six major cell types to enable personalized disease research, drug discovery
Health and economic air quality co-benefits of stringent climate policies
How immune cells deliver their deadly cargo
How the brain becomes a better listener: How focus enhances sound processing
Processed fats found in margarines unlikely to affect heart health
Scientists discover how leukemia cells evade treatment
Sandra Shi MD, MPH, named 2025 STAT Wunderkind
Treating liver disease with microscopic nanoparticles
Chemicals might be hitching a ride on nanoplastics to enter your skin
Pregnant patients with preexisting high cholesterol may have elevated CV risk
UC stroke experts discuss current and future use of AI tools in research and treatment
The Southern Ocean’s low-salinity water locked away CO2 for decades, but...
OHSU researchers develop functional eggs from human skin cells
Most users cannot identify AI bias, even in training data
Hurricane outages: Analysis details the where, and who, of increased future power cuts
Craters on surface of melanoma cells found to serve as sites for tumor killing
Research Spotlight: Mapping overlooked challenges in stroke recovery
Geographic and temporal patterns of screening for breast, cervical, and colorectal cancer in the US
[Press-News.org] Transforming hydrogen into liquid fuel using atmospheric CO2EPFL scientists have completed their solution for transforming hydrogen gas into a less flammable liquid fuel that can be safely stored and transported